Industry News

Bracco Imaging Acquires SurgVision

By Medimaging International staff writers
25 Oct 2017

Image: Bracco Imaging has acquired SurgVision (Photo courtesy of iStock).Bracco Imaging S.p.A. (Milan, Italy), a diagnostic imaging company, has acquired SurgVision ('t Harde, The Netherlands), which focuses on developing a real-time Fluorescence image guided surgery platform combining targeted imaging agent and a device for efficient tumors visualization during oncology surgical procedures.

Bracco Imaging S.p.A., a part of the Bracco Group, offers products and solutions for all key diagnostic imaging modalities, such as X- ray imaging (including computed tomography, interventional radiology, and cardiac catheterization), magnetic resonance imaging, contrast enhanced ultrasound, and nuclear medicine through radioactive tracers. It also offers various medical devices and advanced administration systems for contrast imaging products in the fields of radiology.

Fluorescence image guided surgery is an intra-operative optical technique to assist surgeons in distinguishing tumors from surrounding tissue, using a combined infrared camera and contrast agent approach. SurgVision's targeting solution is expected to provide significant improvements as compared to competing modalities and products, due to advanced features of its optical camera and sensitive targeting performance of its new imaging agent.

"With the acquisition of SurgVision, one of the most advanced companies in a very promising field, we intend to address a relevant, unmet medical need for oncology patients who have to undergo tumor removal surgery," said Fulvio Renoldi Bracco, Chief Executive Officer at Bracco Imaging. "SurgVision platform expands our imaging solutions for healthcare professionals in oncology and reinforces our long-lasting commitment to patient care."

"The investment in Surgvision provides Bracco Imaging with key competencies and technologies strategically adjacent to our core business," said Micol Fornaroli, Chief Strategy Officer at Bracco Imaging. "And at the same time, it will accelerate the development of the projects currently in scope of our Research and Development efforts."

"The acquisition of SurgVision by Bracco is a vote of confidence for the field of fluorescence image- guided surgery and for the achievements so far by the SurgVision team," said Ton van den Hoven, Chief Executive Officer at SurgVision. "The expertise and commitment from Bracco will allow SurgVision to continue developing a solution that delivers on the potential of important clinical benefits for patients."



E-mail Print
FaceBook Twitter Google+ Linked in

Bracco

Offers products, injectors and solutions portfolio for all diagnostic applications from constrast media to medical devices and advanced imaging agents injection systems
More info

More articles about Bracco

06 Jul 2019
Bracco Imaging Acquires Blue Earth Diagnostics to Expand Portfolio
Bracco Imaging S.p.A. has signed a definitive agreement to acquire Blue Earth Diagnostics, a molecular imaging company.
Read More
05 Apr 2017
Bracco Imaging Announces Strategic Investment in PHS Technologies Group
Bracco Imaging S.p.A., which develops, manufactures and markets diagnostic imaging agents and solutions, has announced a strategic investment in PHS Technologies Group, LLC, which is a division of PACSHealth, LLC, a medical software development company.
Read More

Additional news

30 May 2020
MEDICAL FAIR ASIA 2020 Set to Take Place in Singapore from 9-11 December 2020
MEDICAL FAIR ASIA 2020 is set to take place in Singapore from 9-11 December 2020 at Marina Bay Sands, with the exhibition featuring the latest medical technology and innovations, and healthcare equipment and supplies.
Read More
20 Apr 2020
Nova's Stat EMS Basic Blood Testing System Launched in CE Mark Countries
Nova Biomedical (Waltham, MA, USA) has launched the Stat EMS Basic blood testing system for ambulance and emergency care in CE mark countries. Stat EMS Basic measures fingerstick capillary lactate, glucose, ketone, hemoglobin, and hematocrit in six to 40 seconds with laboratory-quality results.
Read More
20 Apr 2020
Nova's Stat Profile Prime Plus Blood Gas Analyzer Receives FDA Clearance for POC Use
Nova Biomedical (Waltham, MA, USA) has secured clearance from the US Food and Drug Administration (FDA) for its Stat Profile Prime Plus critical care blood gas analyzer for point-of-care (POC) use.
Read More
17 Apr 2020
ECR 2020 to Go Ahead as Online Congress on July 15-19, 2020
In view of the ongoing spread of COVID-19 across the world and its growing global impact, the board of directors of the European Society of Radiology (Vienna) has decided not to hold an onsite European Congress of Radiology (ECR) in 2020. Instead, ECR 2020 will go ahead as an online congress to ensure a safe experience for its members, partners, staff and the general public.
Read More
08 Apr 2020
Nova Biomedical Adds PT/INR Test to Allegro Analyzer for POC Testing
Nova Biomedical (Waltham, MA, USA) has added PT/INR testing for its Allegro capillary blood analyzer for point-of-care (POC) testing in primary care settings. With the ability to test for clotting disorders and monitor the effectiveness of blood-thinning medications, the Allegro and its StatStrip-A companion meter provide 18 clinically important tests to help physicians make therapeutic decisions and adjustments at the POC.
Read More
01 Apr 2020
SymphonyAI Acquires TeraRecon
SymphonyAI Group (Los Altos, CA, USA), an operating group of leading business-to-business artificial intelligence (AI) companies, has acquired TeraRecon (Durham, NC, USA), an advanced visualization and AI solution provider for medical imaging.
Read More
23 Mar 2020
Artificial Intelligence-Based Methods to Cut MRI Read Times Receives USD 250K Grant
 Research to detect and predict blocked arteries and cardiovascular risk using knee MRI images conducted by Chun Yuan, Ph.D., Professor of Radiology and Bioengineering and Vice Chair for Global Affairs at the University of Washington (Seattle, WA, USA) has been recognized and awarded a grant by the American Heart Association’s (AHA) Institute for Precision Cardiovascular Medicine (Dallas, TX, USA).
Read More
23 Mar 2020
Surgical Robots Market to Reach USD 13.1 Billion by 2027 Due to High Acceptance in Emerging Regions
 The global surgical robots market is forecasted to reach USD 13.1 billion by 2027, driven mainly by low turn-around times and increased innovation in robotics over the coming years. Surgical robots are finding increased acceptance in the emerging Asia region, according to a study by Transparency Market Research (Albany NY, USA), a next-generation market intelligence provider. The study is based on recent findings by IEEE (an Association for Electronic Engineering) that millennial parents are increasingly opting for robotic surgeries for their children in Asia Pacific region. The study also reveals that low availability of robotic surgeries remains a concern.
Read More
19 Mar 2020
Advantech Launches Medical-Grade AVAS-400 Series 4K UHD Video Recorder
 Advantech Co., Ltd. (Taipei, Taiwan), a provider of medical computing platforms and solutions, has launched its AVAS-400 Series medical-grade 4K ultra high-definition (UHD) video recorder aimed at ensuring operating precision. Advantech’s AVAS-400 Series, which includes two models, the AVAS-401 and the AVAS-402, are ideal for surgery centers, operating rooms, and training facilities that use 4K UHD cameras and display monitors for surgical operations and post-surgery reviews and research.
Read More
Copyright © 2000-2020 TradeMed.com. All rights reserved. | Terms And Conditions